ReleaseWire

Military communication is all about transferring information across people and geography. A secure and robust communication system in the military sector is a prerequisite to provide timely connectivity, exercise authority, and direct forces across geographies. Hence, the military communications system must integrate emerging technologies such as Ka-band, Advanced Extra High Frequency (AEHF) band satellite communication, IP-based networking, Commercial off-the-shelf (COTS)-based products, and others. Adopting these technologies would facilitate the delivery of the right information to the right location and at the right time in an actionable format. Technologies such as Mobile User Objective System (MUOS) will soon provide secure mobile network communication, globally. The future perspective of growth in military communications is expected to be positive, considering the rise in demand for new technologies and updated communication techniques.

The major growth drivers of the Next-Generation Firewall market include increased adoption of BYOD and IoT trend, the rise in internal and external threats, and high functionalities NGFW solutions. The NGFW market is segmented by solution type, services type, organization size, industry vertical, and region. The NGFW market by solution includes hardware, virtual, and cloud-based solutions. The hardware (physical) segment in the NGFW solution market is expected to have the largest market in terms of size, during the forecast period. The market for services segment is growing as the individuals, SMEs, and large enterprises are concerned about the secured accesses to their networking devices. The professional services segment is expected to have the largest market share and dominate the NGFW market during the forecast period, as more and more companies are adopting NGFW solutions and services to secure their business infrastructure from advanced threats such as, ransomware, APTs, zero day attacks, malware, and unauthorized accesses.

The oil and gas security market is estimated to grow from USD 26.34 Billion in 2015 to USD 33.90 Billion by 2020, at a Compound Annual Growth rate (CAGR) of 5.2%. The major drivers driving the market include the increased penetration of Bring Your Own Device (BYOD) and data sharing among various oil and gas installations and need to assess the vulnerabilities of variety of oil and gas installations.

Operation support system (OSS) & business support systems (BSS) are processes that support the back office activity as well as the activities that take place while interacting with the customers over the network. OSS is liable for managing faults in the network, configuration of networks, and security and service assurance. BSS is accountable for managing rating, billing, revenue assurance, business intelligence, product management, fraud management, and customer management. Research Cosmos expects the global operation support system market to grow from USD 23.95 Billion in 2015 to USD 42.81 Billion by 2020, at a CAGR of 12.3 %. The key driver of OSS/BSS market is the cost-effective business process to gain competitive edge in the industry.

Research Cosmos forecasts the premium A2P and P2A messaging market size to grow from USD 55.49 Billion in 2016 to USD 71.60 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 5.23% from 2016 to 2021. Increasing mobile subscriber base, indispensable requirement to have ubiquitous and direct personal communication channel for enterprises to interact with their customers, rising use of mobile banking, creation of new business revenue for stakeholders (specially mobile network operators), and increasing use of messaging services across various business verticals are some of the driving forces in the market.

Research Cosmos forecasts the Security as a service market size to grow from USD 3.12 Billion in 2015 to USD 8.52 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 22.2%. The increasing cloud adoption among the enterprises, to reduce cost and increase operational efficiency, has created demand for cloud security. The major factors contributing to the growth of the market are increasing demand for cloud-based security, shift from traditional security to advanced security, and high on-premise security costs for organizations.

Regarding the vendor landscape, the global cardiopulmonary stress testing systems market boasts the presence of large companies such as Koninklijke Philips N.V., Hill-rom Holdings Inc., General Electric Company, MGC Diagnostics Corporation, OSI Systems Inc., Masimo, NIHON KOHDEN CORPORATION, COSMED, Halma plc, Schiller AG, and Vyaire Medical Inc. among others. This renders a high degree of competition amongst these companies. In this scenario, players have been heavily relying on developing technologically advanced devices to stay strong in this market. The emergence of emerging market players at an exponential rate to develop ancillary devices needed for cardiopulmonary stress testing is a notable trend observed in this market.

Global Smart Cities Market Analysis and Forecast to 2022 | Growth Opportunity Assessment

Global Smart Transportation Market Analysis and Forecast to 2022 | Growth Opportunity Assessment

The major growth drivers of the Next-Generation Firewall market include increased adoption of BYOD and IoT trend, the rise in internal and external threats, and high functionalities NGFW solutions. The NGFW market is segmented by solution type, services type, organization size, industry vertical, and region. The NGFW market by solution includes hardware, virtual, and cloud-based solutions. The hardware (physical) segment in the NGFW solution market is expected to have the largest market in terms of size, during the forecast period. The market for services segment is growing as the individuals, SMEs, and large enterprises are concerned about the secured accesses to their networking devices. The professional services segment is expected to have the largest market share and dominate the NGFW market during the forecast period, as more and more companies are adopting NGFW solutions and services to secure their business infrastructure from advanced threats such as, ransomware, APTs, zero day attacks, malware, and unauthorized accesses.

Global DNA Chip Market: Snapshot

Dual chamber injectors and syringes aremedical devices used to store active pharmaceutical components or biological substances (such as tissue, blood or serum) that are not stable for extended period of time. These devices helps to maintain sterility of drugs before the time of injection in order to avoid drug loss.For example, liquid proteins drugs require refrigeration before dispensing thus, dual chamber injectors and syringes helps to manage proper storage condition of these drugs. Thus, proper storage of these drugs reduces the adverse effects of drug delivery.

Over the past three decades, imaging market has undergone an extensive transformation both in clinical and non-clinical arenas. Clinical imaging is now an important part of the expensive research and development process of pharmaceutical and biotechnology industries. The usage of medical imaging is now recognized in clinical-trials, to make trials more effective and accurate. Clinical imaging delivers information of human anatomy/ physiology, varying from undeniable interpretable information to information that is of uncertain value. The image presenting long fractured bone is simply understood rather than a distribution of uncharacterized ligand receptor in cerebral cortex, is pointless. The clinical inferences of an image are important in evaluating the drug effect. Clinical imaging is used on daily basis to prevent, detect, treat and manage various diseases or medical conditions.

Corneal Implants, also known as corneal inlays are optical devices that are inserted into the cornea to improve reading vision. The chief purpose of these optical devices is to improve near vision and reduce the need for reading spectacles in older adults who have presbyopia. It has been estimated that presbyopia affects nearly over 80-90% population over the age of 40 years worldwide. Corneal implantable devices are one of the options for rectification of decreased near vision in presbyopic people who desire to have spectacle-independent superior vision at all distances. Corneal implantable devices do not restore the ability to accommodate, however, they work by increasing the depth of focus or the refractive power of the central or paracentral part of the cornea. Corneal implantable devices have also been used for correction of hyperopia, myopia, and astigmatism. Adults who are in their middle age start experiencing symptoms of difficulty in reading and often are compelled to resort to wearing spectacles for the same. However, many people have an inherent stigma or dislike associated with wearing glasses since it is believed to hamper looks. Many people in their middle age often resort to procedures which would make them look younger than their age. Moreover it is inconvenient to carry a spectacle case around everywhere one goes. This consumer behavior, which is the personal preference by many to go spectacle-free shall drive the growth of the corneal implantable device market. Currently, commercially available corneal implantable devices include the Kamra Inlay, the Presbia Flexivue Microlens, the Raindrop Near Vision Inlay and the Icolens.

Electrodes are conductors capable of passing energy signals from one medium to another i.e. from a power source to a material or device. The electrodes are composed especially of metals such as copper, zinc, silver, nickel, cadmium, manganese oxide and others. In medical applications electrodes facilitate diagnosis as well as treatment of several disease conditions. For instance electrocardiography ECG electrodes are employed to diagnose cardiac disorders whereas electrosurgical electrodes are deployed in various surgeries to ensure precise incisions with minimal loss of blood.

Primary Immunodeficiency Diseases Market: Key Insights

The rising use of collagen in medical devices and drug delivery systems, increased preference for minimally invasive technologies, and the effectiveness in wound healing are expected to be some of the key factors driving the global demand for collagen in the coming years. Easy availability of a number of collagen sources and the low antigenicity of the material grant collagen an important position in a number of industries such as pharmaceuticals, food and beverages, and cosmeceuticals.

The North America porcine vaccine market is highly fragmented owing to the presence of numerous large and small players. Zoetis, Inc., Merial Animal Health, Merck Animal Health, and Elanco Animal Health are the top four players that accounted for around 74.0% of entire market in 2015. Some of the other key palyers in the market are Bimeda Animal Health, Bayer AG., Boehringer Ingelheim GmbH, Vetoquinol, and Ceva Santé Animale. All these players are working on building diverse product portfolios, indulging in mergers and acquisitions, and investing in research and development activities in order to launch new and more effective vaccination for porcine. For example, Boehringer Ingelheim GmbH launched two new porcine vaccines ReproCyc and Ingelvac.

Global Chlamydia Infection Diagnostics and Therapeutics Market: Snapshot

The global allergy treatment market is characterized by the dominance of a handful companies, namely ALK-Abelló A/S, Sallergenes Greer, and GlaxoSmithKline that hold leading revenue share, states Transparency Market Research (TMR) in a new report. The dominance of these companies is mainly because of their impressive product portfolio and extensive geographical outreach.

In a moderately consolidated global orphan drugs market, players are primarily focused on strategic acquisitions and are strategizing to gain maximum returns on investments made for R&D of orphan drugs and to leverage the incentives offered by governments for research on orphan drugs, according to recent market intelligence by Transparency Market Research. In this scenario, some of the companies to hold a commanding position in the global orphan drugs market are Novartis AG, Celgene Corporation, Pfizer Inc., Alexion Pharmaceuticals Inc., GlaxoSmithKline plc, and Johnson & Johnson.

Growing prevalence of various blood diseases such as anemia, myeloma, leukemia and sickle cell anemia has led the hematologists to focus on various detection processes. As demand for comparatively conducting comparatively short diagnosis process is becoming the need of the hour, hematologists are looking for better treatment processes through accurate diagnosis process. With the growing need to detect various blood conditions has further propelled hematologists to focus on enhancing their diagnostic skills. In order to develop successful treatment techniques, hematologist are significantly focusing on early diagnosis of the various hematologist diseases. Bound to these factors, growth of the global hematologist disease treatment market will continue to gain momentum during the forecast period.

Carglumic acid is an orphan drug that is used for treating patients suffering from hyperammonemia, a urea cycle disorder that is caused due to the lack of a certain enzyme in the liver. This also implies deficiency of N-acetylglutamate (NAG) synthase. Carglumic acid helps in detoxification and removal of ammonia from blood cells.

The incidence of dry eye disease is increasing and so is the competition prevailing in the global dry eye disease market. In a recent study, Transparency Market Research (TMR) has predicted positive trajectory for the market, during the course of which it is likely to witness heightened competition. With several market players standing on the brink of patent expiries, investment toward research and development of novel drugs will accelerate. With this, the market can expect increased enrollments in clinical trials. Furthermore, market players are likely to forge strategic collaborations and ink licensing agreements to establish a stronger foothold in the global dry eye disease market. During this time the market will also witness the leading companies backing their powerhouse drugs to cut off rivalry. Some of the leading market players are Novartis AG, Santen Pharmaceutical Co., Ltd., Allergan plc, Valeant Pharmaceuticals International, Inc., Shire plc, TRB Chemedica International SA, Sentiss Pharma Pvt. Ltd., Senju Pharmaceutical Co., Ltd., Mitotech S.A., Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson, and FCI S.A.S.

Global Cancer Cachexia Market: Snapshot